We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Innovaderma Plc | LSE:IDP | London | Ordinary Share | GB00BT9PTW34 | ORD EUR0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
16/1/2017 09:03 | People are thinking very short term, silly really. Why do you think they are going global? Because there is a huge growth potential here. Did not sell 1 share today as they are taking you for a ride. Hold tight as these shares will become as rare as hen's teeth. someone mentioned transfer of wealth is whats going on the back of a cleverly worded RNS. As for Boffster, clever he made a few pounds, shame he doesn't see the big pic. But good riddance as hopefully he gone for good. | andyr42 | |
16/1/2017 09:02 | I agree with Boffster and whilst I was long and had a target of £3-£4 I have sold out on this news. The TU was pretty awful. 80% yoy with easy comparatives is very poor. I was expecting 150% at least. Growth from the second half of FY16 is a paltry 15% and unless they get their act together growth will stall completely. Without exponential growth in these small caps, don't expect exponential share price growth. | croasdalelfc | |
16/1/2017 09:02 | Market overreaction. Anyone would have thought sales were down not substantially up (and well ahead of the Dec 22 broker note estimate +80% v +53%). Always said there would be volatility. Good for the nerves. | the macallan | |
16/1/2017 09:00 | HERE WE GO GOING UP | falia | |
16/1/2017 08:58 | blimey, that escalated quickly, i thought was a decent TU not stunning, but down to 180, never saw that coming, thats why i am still learning, looks like Boftser was spot on. GLA | wholden | |
16/1/2017 08:57 | You have to add in the £8.1m (10m dollars) they will receive from PROS in 2017. | goboy1 | |
16/1/2017 08:52 | So you £3m revenue growing at 80% becomes £5.4m revenue h2, total revenue £8.4m for the year. That includes US sales.Gross profit say £4.8m, valuation isn't as far out as you may think, although I did sell some at 248.5p Friday. | che7win | |
16/1/2017 08:52 | Transfer of wealth going on this morning | thelung | |
16/1/2017 08:52 | PZ Cuzzons paid 3.5x sales or circa £70m for St Tropez a decade ago, versus market cap here interesting and a buy | nw99 | |
16/1/2017 08:49 | Buy and hold and if you still hold like myself top up. Was a ok RNS Feb results will be good we all no its selling like hot cakes around the world forget today's drop as this was always going to happen with quick traders trying to make a few bucks. Sit tight we're be laughing in the end | honestcrook | |
16/1/2017 08:48 | Boffster, The revenue update is for six months, your last post is disingenuous. The second half coming into summer will include US revenue (only starting).Please be accurate. | che7win | |
16/1/2017 08:46 | Thanks Boffster bye | nw99 | |
16/1/2017 08:45 | Good for you Boffster, you are sold out so you can F OFF swiftly. Dont need you back | andyr42 | |
16/1/2017 08:43 | goboy ... any comment on the below ? goboy1 - 09 Jan 2017 - 08:27:52 - 1148 of 1794 Innovaderma - Global Brands and Huge Markets - IDP This should be easily over £16 within a couple of weeks. Rapidly growing sales, product range increasing, about to launch into mainland Europe, trading profitably, takeover potential, etc. It has all the makings of an ideal growth company | onedayrodders | |
16/1/2017 08:43 | No point buying here IMO. No more immenent news, a lacklustre trading statement, and a £22m market cap for only £3m revenue. Better investments around IMO. Have sold the few I bought back and accepted a small dent in my profits | boffster | |
16/1/2017 08:42 | well done ny boy dont see any mention of your sale here so good luck with your new buys, i am so glad you have informed us of what you are doing with your life today, ever thought of doing a blog ? | arab3 | |
16/1/2017 08:40 | Interims out next month and will show the 80% increase in revenues with even more to come so will get some good press coverage. Time to be buying. | goboy1 | |
16/1/2017 08:38 | Used some profits from here to buy (CLNR) @ just over 3p which had a v good trading update.dyor as usual as I just buy what I feel has share price growth potential from a low base. | ny boy | |
16/1/2017 08:35 | Good job the clever ones pulled the lot at 240!! Well done!! | potential | |
16/1/2017 08:35 | CSM it was all small sells trying to buy 10k took ages as size was too big normal trade size just 1500 shs . If you are med long term investor this is a wonderful buying op. | nw99 | |
16/1/2017 08:34 | I understand Hybridian are house broker. Hopefully something from them soon. Nothing goes up in a straight line and this stock has attracted some hot money. Sometimes this kind of price action is good because it shakes out the hot money, allowing the price to consolidate, build a base and then appreciate in a steadier fashion.Dibbs | dibbs | |
16/1/2017 08:29 | "The RNS was designed to damp down the price" ... beautiful, I like it mad foetus & agree. | andyr42 | |
16/1/2017 08:28 | US sales and benefits of moving production to the UK will show in the second half. As we know PROS will purchase £8m of items in 2017 and £16m of items in 2018 for distribution across SE Asia. Clear and achievable growth story developing here. | goboy1 | |
16/1/2017 08:27 | You can tell who have sold out this morning and trying to trade this, I would not be surprised if this finishes say up, if you look at the volume it's very light, tells me long term holders not willing to sell at these levels imho dyor | csmwssk12hu |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions